microRNA-422a promotes HIV replication and innate immune evasion by targeting MECP2

Area of Science:

• Virology
• Immunology
• Molecular Biology

Background:

• Interferon-alpha (IFNα) exhibits anti-human immunodeficiency virus type I (HIV-1) activity.
• Understanding HIV-1's innate immune evasion mechanisms is crucial for developing better antiviral strategies.
• MicroRNA miR-422a was previously found to be downregulated by IFNα in people living with HIV (PLWH), correlating with viral load reduction.

Purpose of the Study:

• To investigate the molecular mechanisms linking miR-422a and IFNα's anti-HIV-1 effects.
• To determine the role of miR-422a in HIV-1 replication and innate immune evasion.
• To explore the potential of targeting the Nef-miR-422a-IFNα axis for virologic control.

Main Methods:

• Investigated miR-422a expression in primary CD4+ T cells during HIV-1 infection.
• Utilized transcriptomic analysis to identify targets of miR-422a.
• Employed miR-422a overexpression and CRISPR-Cas9-mediated MECP2 knockout to assess effects on IFNα antiviral capacity and HIV-1 replication.

Main Results:

• HIV-1 infection induces miR-422a expression in CD4+ T cells via the viral Nef protein.
• miR-422a enhances HIV-1 replication by directly targeting methyl CpG binding protein 2 (MECP2).
• miR-422a depletion mimics IFNα by inducing IFN-stimulated genes (ISGs) that restrict HIV-1; conversely, miR-422a overexpression or MECP2 knockout counteracts IFNα's antiviral effects and rescues HIV-1 replication.

Conclusions:

• miR-422a is a key host factor induced by HIV-1 that promotes viral replication and subverts type I IFN responses by targeting MECP2.
• The Nef-miR-422a-IFNα axis represents a potential therapeutic target for achieving virologic control in people living with HIV.
• Pharmacologic manipulation of this axis could offer novel antiviral strategies against HIV-1.